Click Here to
receive daily
reports of the
TOP PICKS
OR
your personal
stock choices

STOCKCHASE

What the experts are saying!
This site compiles comments that experts make about stocks while on public TV shows.

There are 3 registered members and 56 guests viewing the site. Follow us on Twitter Rss Top Picks FeedRss Daily Feed

Boston Scientific Corp
Symbol: BSX-N
Active: Y
Sector: biotechnology/pharmaceutical
Last Price: 5.960
Last Price Date: 2012-05-21 01:14:03
Globe 200 day average
Google Discussions (view only)
Yahoo Discussions (participate)

Experts who have talked about Boston Scientific Corp

DON'T BUY5.330Gordon ReidIn the last 9 months they had their heart defibrillator withdrawn from the US market because of FDA problems. Would steer clear of this one.2010-09-14
DON'T BUY15.950Ross HealyHad an earnings disappointment. FMV trend is sharply down. When factoring in analysts forecasts, the FMV is about $12.30.2007-03-07
BUY on WEAKNESS23.170Brian Acker, CAWill have to go to $20.50 before it has a bounce. Has a model price of $31.95 which is a 37/38% differential.2005-09-21
BUY26.210Gavin GrahamIn a lawsuit with Johnson and Johnson (JNJ-N), so a lot depends on who wins the case. Their product works better than JNJ and he continues to like it.2005-09-06
BUY27.480Gavin GrahamThings look good for them. Won a patent case against Johnson & Johnson (JNJ-N).2005-07-13
WEAK BUY30.600Brian Acker, CAIt's close to a buy. Model price is $32.09 which is a 5% differential.2005-05-24
TOP PICK30.000Kevin Vandermeer, B.Comm, CFA"We really like Boston [Scientific]" Thinks they have a better product then the competitor. Had a series of recalls, but have been able to gain back the marketshare. But the stock didn't recover as well. So is now undervalued.2005-03-11
DON'T BUY34.810Ron MeiselsLong term chart shows that it made a base, had a fantastic rise to $45 in 2002/2003, very little top formation and now we are in a downtrend. Stock has now fallen below its 200 day moving average.2005-02-01
BUY31.880David BaskinA good company. Their coated stents is a terrific product. Up against Johnson & Johnson in the stent business, but they are holding their own. A good buy at this price.2005-01-25
WEAK BUY32.370Brad WillockStock has dropped because of the recall of their stent. Price is reasonably attractive.2004-08-13
TOP PICK44.300Mary FarrellA company that focuses on earnings. A tremendous new product that should give a nice boost to their income.2004-05-28
DON'T BUY41.500Matt BaraschIts drug coated stent is driving the price up, but other competitors are lurking on the horizon. Not cheap.2004-02-19
TOP PICK48.000David BurrowsLikes this sector. Strong and persistant growth. Revenue and earnings growth has been very persistant. Good products. Buy on pull backs.2003-05-13

Privacy Policy